During the past decade, Neurological Associates, Inc. conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neurological Associates, Inc." #1 sponsor was "EMD Serono Research & Development Institute, Inc." with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "ACADIA Pharmaceuticals Inc." with 1 trials sponsored, "Acorda Therapeutics" with 1 trials sponsored and "Beth Israel Deaconess Medical Center" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neurological Associates, Inc." #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Elan Pharmaceuticals" with 1 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Neurological Associates, Inc." are "Multiple Sclerosis" (6 trials), "Acute Brainstem/Cerebellar Syndrome" (1 trials), "Alzheimer Disease" (1 trials), "Alzheimer's Disease" (1 trials) and "Autoimmune Diseases of the Nervous System" (1 trials). Many other conditions were trialed in "Neurological Associates, Inc." in a lesser frequency.

Most popular intervention types in "Neurological Associates, Inc." are "Drug" (12 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Cladribine Tablets" (2 trials), "C105" (1 trials), "Dalfampridine-ER 10mg" (1 trials) and "Dalfampridine-ER 5mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurological Associates, Inc." are 14 trials for "All" genders.

Currently, there are NaN active trials in "Neurological Associates, Inc.". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Neurological Associates, Inc., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Neurological Associates, Inc., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".

Neurological Associates, Inc. has several departments that took part in Clinical trials: "Cardiothoracic Surgical Associates" - 2 trials, "Retreat Cardiology LLC, dba Cardiology Associates of Richmond" - 2 trials